Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kinesis Pharma is a specialized contract research organization (CRO) providing strategic and operational consultancy services for drug development. Based in the Netherlands, the company focuses on the transition from discovery to early clinical phases, offering expertise in regulatory affairs, chemistry, manufacturing, and controls (CMC), non-clinical development, and clinical pharmacology. Kinesis serves a global client base of biotech and pharmaceutical companies, providing integrated solutions to accelerate drug development timelines. The company is recognized for its deep expertise in navigating European and US regulatory environments. In 2015, Kinesis Pharma was acquired by Venn Life Sciences to strengthen its early-stage development and regulatory capabilities, and it is now part of the hVIVO group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kinesis Pharma.